The Lifting of Vaccine Patents has Never been More Urgent. What is Vivaldi Waiting for?
While a third vaccine dose is being administered in Europe, patents deny other countries access to the vaccine. The latest virus variant shows how dangerous that is. The lifting of vaccine patents has never been more urgent.
The discovery of the latest Covid variant pushed the stock prices of Pfizer and Moderna up considerably. Pfizer saw its stock close to 6.1 percent higher, about an additional $17.5 billion in market value. Competitor Moderna even saw its shares rise by 21 percent. A virus variant as a business opportunity. That's highly cynical for more than one reason. After all, it is precisely the patents of Big Pharma that make new variants more likely.
Patents protect vaccine technology from other countries and companies. That limits vaccine production and increases glob...